A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04649151

Recruitment Status : Active, not recruiting

First Posted : December 2, 2020

Last Update Posted : March 5, 2021

Sponsor:

Collaborator:

Biomedical Advanced Research and Development Authority

Information provided by (Responsible Party):

ModernaTX, Inc.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	June 30, 2022
Estimated Study Completion Date :	June 30, 2022

To Top